<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/9486213/0d2ab160a7fc/fonc-12-1006516-g002.jpg"/> </div> <div class="text-side"> <h1>Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation.</h1> <p>The hematoxylin–eosin (H&amp;E) and immunohistochemical pictures of the tumor. (A) H&amp;E, original magnification, ×100. (B) H&amp;E, original magnification, ×400. Immunohistochemistry: CKpan (C), Vementin (D), EMA (E), P63 (F), and S100 (G).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36147925/" target="_blank">36147925</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>